FORTY FOUR PHARMACEUTICALS SP Z O O has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in China, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PLEDPHARMA AB, TARO PHARMACEUTICALS NORTH AME and LIMERICK BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Israel | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Taiwan | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Turski Christopher | 10 |
Publication | Filing date | Title |
---|---|---|
US2021046097A1 | NEUTRAL ENDOPEPTIDASE (NEP) AND HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) INHIBITORS FOR PROPHYLAXIS AND TREATMENT OF EYE DISEASES | |
CN111989112A | Neutral Endopeptidase (NEP) and Human Soluble Endopeptidase (HSEP) inhibitors for reducing the deleterious effects of organ hypoperfusion |